|
|
Pandemic's VC deal toll: Midyear perspective
|
|
With two days left in the first half of 2020, midyear figures show the toll that the venture capital ecosystem has suffered from the worst economic downturn in nearly a century.
It's no surprise that the US venture market has slowed down dramatically and remains on pace to end 2020 well below high levels seen in the past two years. But there are some bright spots, according to PitchBook data covering deals made as of June 17:
- VC investment is down from last year at this time but invested capital is still holding well above levels seen in comparable periods of recent years. Investors bet $63.2 billion on VC-backed deals, down from $72.2 billion in the last year's first half.
- Deal flow has fallen more sharply, however, with 4,675 funding rounds this year vs. 6,357 in last year's first half.
- One segment of the market that has held up: mega-rounds. Deals of $100 million or more are a bit behind last year's first-half tally, but the rough $29 billion sum of mega-fundraising rounds puts this category on track to surpass last year's $55 billion, the second-biggest haul on record.
- By contrast, as would be expected during these panicky times, investors held onto their seed capital. Deals plunged 45% to 803 vs. 1,447 deals done in the first half of 2019, with invested capital down to $2.2 billion from $3.3 billion. Dealmaking goes on, but it's clearly favoring well-established players.
—Alexander Davis
|
|
|
|
|
|
|
Amazon joins ranks of Ford, Uber and GM with Zoox purchase
|
|
|
(Gabe Pierce/Unsplash) |
|
|
Last Friday, Amazon announced it had bought self-driving vehicle company Zoox. The startup reportedly had a round of layoffs in April and faced difficulties raising new cash. Its sale resulted from a wide range of challenges that come from keeping a company in the autonomous driving space afloat.
- The deal was reportedly valued at $1.2 billion, a significant haircut from the $3.2 billion figure the startup reached less than two years ago
- It also brings ecommerce giant Amazon into the ranks of other corporate efforts to build autonomous vehicles
|
|
|
|
|
|
|
|
|
Set yourself up for post-COVID success
|
|
How can businesses thrive as the COVID-19 haze lifts and market conditions improve? Capital raisings are a proven way to bolster a company's financial position and execute on opportunities as they arise. But the process can be risky.
The key is momentum—the longer a deal runs, the more risks and costs it takes on. And the faster capital can be secured, the more certain a business' future.
Ansarada's "Capital Raise Pathways" (debt, equity, and debt & equity) are digitized checklists that outline the documentation required and automate the steps to take to ensure a swift and secure raise. Companies and their advisors can be confident they are presenting the business in its best light to investors and driving an optimal, transparent result for all parties.
Download the "Raising Capital" guide and get access to a 14-day, no-obligation free trial. |
|
|
|
|
|
|
|
Oscar nabs $225M as pandemic disrupts healthcare
|
|
|
(masa44/Getty Images) |
|
|
Health insurance provider Oscar has landed $225 million in new funding from investors including Baillie Gifford, Coatue Management, Alphabet and General Catalyst.
The New York-based startup has raised around $1.5 billion in total financing, making it the most well-funded VC-backed health insurance company, according to PitchBook data.
With $2 billion in revenue, Oscar has benefited from a consumer shift toward buying health insurance directly from a provider, rather than through an employer or broker. It has also been a leader in telemedicine, which has surged during the pandemic. Oscar recently teamed with Cigna in an effort to launch small-business insurance plans.
Joshua Kushner, who started Thrive Capital, co-founded Oscar in 2012. |
|
|
|
|
|
|
Monetizing the software developer population
|
|
The digital IP era is driving organizations to increase investments in software development capabilities. In turn, VCs are targeting technologies that address this need.
Our latest installment of Emerging Tech Research turns a spotlight on the cloudtech and DevOps industry, featuring market maps of venture-backed companies, technology overviews and analysis of opportunities and risks. Key takeaways include:
- DevOps providers raised $6.3 billion in VC in 2019 and $2 billion in Q1 2020
- Increased recognition of DevOps as a strategy to drive digital transformation is fueling investment
- The COVID-19 pandemic could accelerate investment in digital strategies, with vendors of virtual collaboration tools well positioned to benefit
If you have any questions or feedback about the research, we'd love to hear from you: analystresearch@pitchbook.com |
|
|
|
|
|
|
Wondering how the economy reopening will affect your segment of the private markets? Looking for insight into which industries are likely to bounce back faster than others? Curious about what's driving a new trend you've noticed?
Email us at ask@pitchbook.com, and the news team will choose a question and track down the answer. |
|
|
|
|
|
|
Costco is discontinuing its half-sheet cakes due to the pandemic. [The New York Times]
The credit crunch that's hit many companies during the crisis has caused Apollo Global Management to thrive. [Reuters]
Restaurant spending is a key indicator of where the next virus spike may be, according to data collected by JP Morgan. [Bloomberg] |
|
|
|
|
|
|
|
|
Since yesterday, the PitchBook Platform added:
|
|
|
|
|
|
|
|
|
|
|
2011 Vintage Global PE Funds with more than $1B
|
|
|
|
|
|
|
|
Alexis Ohanian steps away from Initialized Capital
|
|
Reddit co-founder Alexis Ohanian plans to leave Initialized Capital, the VC firm he co-founded eight years ago, according to Axios. Ohanian will remain involved with some current Initialized portfolio companies, but will otherwise shift his focus to pre-seed investing. He also stepped down from Reddit's board earlier this month. |
|
|
|
|
|
|
|
Gates Foundation leads $45M round in agtech startup Enko
|
|
Enko Chem has raised a $45 million Series B led by the Bill & Melinda Gates Foundation, with participation from Finistere Ventures, Novalis LifeSciences and others. The startup's tech platform is used to discover new ways to protect crops from pests and diseases. The Gates Foundation was driven to invest in the startup because of the potential for its technology to help smallholder farmers in sub-Saharan Africa and South Asia. |
|
|
|
|
|
|
|
Healthy.io to snap up rival Inui Health
|
|
Israeli startup Healthy.io has agreed to buy one of its competitors in the urinalysis space, Inui Health, according to CNBC. Healthy.io is reportedly paying $9 million in a cash deal contingent upon the acquired company meeting certain milestones. California-based Inui Health, formerly known as Scanadu, has raised about $58 million since 2012. It was valued at $131.5 million with a funding round in 2016, according to PitchBook data. |
|
|
|
|
|
Agora shares skyrocket in Nasdaq debut
|
|
Shares in Agora more than doubled in value in their first trading day on the Nasdaq, closing Friday at $50.50, up more than 150% from a $20 IPO price. The Shanghai-based provider of real-time engagement APIs raised $350 million in the offering, which it priced at $20 per American depositary share, above the marketed range of $16 to $18. Agora received prior funding from VC backers including Coatue Management and Shunwei Capital. |
|
|
|
|
|
|
|
Base10 doubles down on diversity with $250M fund
|
|
San Francisco's Base10 Partners has closed its sophomore fund on $250 million, bringing the firm's assets under management to over $400 million, according to a Medium post. The vehicle will invest in companies seeking to address issues like racial, economic and gender inequality. Base10 has also announced its VC diversity pledge, underlining the Black-led firm's commitment to inclusion and equality in the industry. |
|
|
|
|
|
Aisling Capital locks down $144M for life sciences
|
|
Aisling Capital has secured just over $144 million for its fifth fund, according to an SEC filing. The New York-based firm invests solely in healthcare companies, with a portfolio that includes oncology drug developer Nuvation Bio and food-allergy treatment provider Aimmune Therapeutics. |
|
|
|
|
|
Lightship Capital pulls in $50M
|
|
Lightship Capital, the Cincinnati-based firm co-led by husband and wife Brian Brackeen and Candice Brackeen, has closed a $50 million fund, according to The Wall Street Journal. The vehicle will focus on underrepresented founders in the Midwest. The firm's portfolio includes moving company The Home Team and Proov, a provider of fertility services for women. |
|
|
|
|
|
|
|
|
|
|